Concord Biotech Limited

Concord Biotech Limited IPO

BSE, NSEClosed
Aug 4, 2023Open Date
Aug 8, 2023Close Date
TBAAllotment Date
Aug 18, 2023Listing Date

Subscription Details

View Subscription Details
Retail3.77x
Employee24.39x
QIB67.67x
NIIs (Non-Institutional Investors)Main Category
16.99x

↳ NII Sub-Categories

sHNI (< ₹10L)

Bids ₹2L to ₹10L

12.36x

bHNI (> ₹10L)

Bids above ₹10L

19.30x

Overall Subscription

Total Bids Received

24.86x

Updated: 10 Jul, 06:09 pm

Concord Biotech Limited IPO Issue Details

Issue Price₹705-741 Per Equity Share
Face Value₹1 Per Equity Share
Listing AtBSE, NSE
Listing DateAug 18, 2023

Company Information

Concord Biotech Limited is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppr...

Valuations

RoNW

20.06%

Financial Information (₹ in Crores)

MetricFY 23FY 22FY 21
Total Assets1513.981312.81182.55
Total Revenue888.48736.35630.75
Profit After Tax240.08174.93234.89
Net Worth

* All figures are in ₹ Crores unless otherwise stated.

Objectives of the Issue

  1. 1Achieve the benefits of listing the Equity Shares on the Stock Exchanges.
  2. 2Carry out the Offer for Sale of up to 20,925,652 Equity Shares by the Selling Shareholder.

Concord Biotech Limited – Promoter(s)

Mr. Sudhir Vaid
Mr. Ankur Vaid

Contact Details

Visit Website

Concord Biotech Limited IPO Documents

DRHP
RHP
ANCHOR

Frequently Asked Questions — Concord Biotech Limited IPO

Download Mobile App

Get push notifications instantly when IPO allotment goes live!

GET IT ONGoogle Play
DOWNLOADApp Store

Angel One

Free Demat

Zero Brokerage Equity

Angel One
Open Account Now

Zerodha

Free Demat

India's #1 Stock Broker

Zerodha
Open Account Now

Upstox

Free Demat

Instant Demat Account

Upstox
Open Account Now